Michelle Gervino Discusses Side Effect Management in Patients with Hematologic Malignancies
Michelle Gervino, RN, BSN, OCN, John Theurer Cancer Center, discusses side effects that patients with hematologic malignancies may experience during treatment
Becoming Familiar With Patients’ AEs is Essential, Says Expert
Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC
Tivozanib Combo Yields Similar PROs to Monotherapy in Advanced Clear Cell RCC
Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC
Redeployment Engages Oncology PA Skills, Reduces Burnout
Biocartis Launches qPCR POLE/POLD1 Mutational Assay
Evaluating Options for Second-Line HR+, HER2- Breast Cancer Treatment
First-Line Amivantamab With Lazertinib Boosts OS in EGFR-Mutated NSCLC